Alexandre Marchand

Université Paris-Saclay — France

Medicine · Health Sciences

22h-index1.7kcitations82works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Erythropoietin and Anemia Treatment(18), Hormonal and reproductive studies(10), Biosimilars and Bioanalytical Methods(10), Muscle metabolism and nutrition(8), Growth Hormone and Insulin-like Growth Factors(6)

Publications82 total

Detection of a Distinct Erythropoietin (EPO) Profile After Isoelectric Focusing in Patients With Familial Erythrocytosis
Drug Testing and Analysis·2026Open Access
Improvement of EPO Transgene Detection From Polymeric Dried Blood Spots for Antidoping Application
Drug Testing and Analysis·2025· 2 citedOpen Access
Dopage : passeport biologique de l’athlète et suivi longitudinal
EMC - Biologie Médicale·2025
Combined detection of inhibitors of the activin receptor signaling pathways (IASPs) by means of LC-HRMS/MS for human doping control
Scientific Reports·2025· 1 citedOpen Access
Identification of Hepatic-like EPO as a Cause of Polycythemia
New England Journal of Medicine·2025· 10 cited
Evaluating the Early Operational Performance of the Endocrine Module in the Athlete Biological Passport
Drug Testing and Analysis·2025· 3 cited
Impact of Menstrual Cycle and Oral Contraceptives on Haematological and Inflammatory Biomarkers in Highly Trained Female Athletes
Drug Testing and Analysis·2025· 3 citedOpen Access
Identification of Hepatic-like Erythropoietin with Enhanced Activity As a New Cause of Hereditary and Acquired Erythrocytosis
Blood·2024· 1 cited
New Transcriptomic Biomarkers for Detection of the Recombinant Human Erythropoietin (rHuEPO) MirCERA in Horses
Drug Testing and Analysis·2024· 2 cited
Olympic Games: When the haematocrit does not fit, the athlete is not always a cheat
Journal of Internal Medicine·2024Open Access
Homologous blood transfusion and doping: Where are we now?
Drug Testing and Analysis·2024· 3 citedOpen Access
Suivi au long terme des répondeurs complets aux inhibiteurs de point de contrôle immunitaire (ICI) ou à la thérapie ciblée (TC) dans le mélanome avancé
Annales de Dermatologie et de Vénéréologie - FMC·2023
Dried blood spots for erythropoietin analysis: Detection of micro‐doses, <i>EPO</i> c.577del variant and comparison with in‐competition matching urine samples
Drug Testing and Analysis·2023· 12 citedOpen Access
Evaluation of the detection of the homologous transfusion of a red blood cell concentrate in vivo for antidoping
Drug Testing and Analysis·2023· 10 citedOpen Access
Effects of Native Whey Protein and Carbohydrate Supplement on Physical Performance and Plasma Markers of Muscle Damage and Inflammation during a Simulated Rugby Sevens Tournament: A Double-Blind, Randomized, Placebo-Controlled, Crossover Study
Nutrients·2022· 5 citedOpen Access
Autologous blood extracellular vesicles and specific CD4+ T-cell co-activation
Frontiers in Immunology·2022· 9 citedOpen Access
Detection of erythropoiesis stimulating agent Luspatercept after administration to healthy volunteers for antidoping purposes
Drug Testing and Analysis·2022· 11 citedOpen Access
Optimizing detection of erythropoietin receptor agonists from dried blood spots for anti‐doping application
Drug Testing and Analysis·2022· 21 citedOpen Access
Functional analyses of two novel <i>LRRK2</i> pathogenic variants in familial Parkinson’s disease
2021Open Access
Development of a microplate duplex immunoassay to simplify detection of growth hormone doping: Proof of concept
Drug Testing and Analysis·2021· 3 cited
page 1 of 5Next →

Frequent Co-authors

Magnus Ericsson(15), Laurent Martin(13), Michel Audran(11), Ingrid Roulland(9), Florian Semence(9), Michèle Garlatti(7), Fabrice Atassi(7), Anne‐Marie Lompré(7), Nathalie Mougenot(6), Corinne Buisson(6), Robert Barouki(4), Sophie Nadaud(3), Robert Barouki(3), Jean‐Antoine Martin(3), Valérie Domergue(3), Augustin Baulig(2), Francelyne Marano(2), Armelle Baeza‐Squiban(2), A. Gaaya(2), Florent Soubrier(2)